DEA Schedule CIV
Strength
.5; 50 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591039501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074736On Market Since
5/21/1997
Pharmacological Classes
Competitive Opioid Antagonists
Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist/Antagonist
Partial Opioid Agonists
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
BUPRENORPHINE 2 MG TABLET SL
Generic
00054017613•Hikma Pharmaceuticals USA Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00121101930•PAI Holdings LLC
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00228315603•Actavis Pharma, Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00904715404•Major Pharmaceuticals
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
42858050103•Rhodes Pharmaceuticals L.P.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
50268012815•AvPAK
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
60687048121•American Health Packaging
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
62756045983•Sun Pharmaceutical Industries Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
72888018230•Advagen Pharma Ltd.
$0.2676
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4698
per EA